Prospect: Information for the user
Lansoprazol Davur 30 mg hard-gastroresistent EFG capsules
Read this prospect carefully before starting to take the medicine, because it contains important information for you.
-Keep this prospect, as you may need to read it again.
-If you have any doubts, consult your doctor or pharmacist.
-This medicine has been prescribedonlyto you and should not be given to other people, even if they have the same symptoms, as it may harm them.
1.What is Lansoprazol Davur 30 mg and what is it used for
2.What you need to know before starting to take Lansoprazol Davur 30 mg
3.How to take Lansoprazol Davur 30 mg
4.Possible adverse effects
5.Storage of Lansoprazol Davur 30 mg
6.Contents of the package and additional information
The active ingredient of Lansoprazol Davur is lansoprazol, a proton pump inhibitor. Proton pump inhibitors reduce the amount of acid produced by the stomach.
Your doctor may prescribe Lansoprazol Davur for the following indications:
-Treatment of duodenal and gastric ulcers.
-Treatment of inflammation of the esophagus (gastroesophageal reflux esophagitis).
-Prevention of gastroesophageal reflux esophagitis.
-Treatment of stomach burning and acid regurgitation.
-Treatment of infections caused by the bacteriaHelicobacter pylori, in combination withantibiotics.
-Treatment or prevention of duodenal or gastric ulcers in patients requiring continuous treatment with nonsteroidal anti-inflammatory drugs (NSAIDs) (NSAID treatment is used for pain or inflammation).
-Treatment of Zollinger-Ellison syndrome.
Your doctor may have prescribed Lansoprazol Davur for another indication or a different dose than indicated in this leaflet. Follow your doctor's instructions regarding the use of the medication.
Do not take Lansoprazol Davur 30 mg:
- If you are allergic to lansoprazol or to any of the other components of this medication (listed in section 6).
- If you are taking another medication whose active ingredient is atazanavir (used in the treatment of HIV).
Warnings and precautions
Inform your doctor if you have a severe liver disease. The doctor may need to adjust the dose.
When taking lansoprazol, it may cause inflammation in the kidneys. Signs and symptoms may include decreased urine volume or the presence of blood in the urine and/or hypersensitivity reactions such as fever, skin rash, and joint stiffness. Inform your doctor of these signs.
Your doctor may perform or have performed a diagnostic test called endoscopy to diagnose your condition and/or rule out a malignant disease.
In case of diarrhea during treatment with Lansoprazol Davur, contact your doctor immediately, as Lansoprazol Davur has been associated with a slight increase in infectious diarrhea.
If your doctor has prescribed Lansoprazol Davur in addition to other medications for the treatment of Helicobacter pylori infection (antibiotics) or together with anti-inflammatory medications to treat pain or rheumatism, read the leaflets of these medications carefully.
The fact of taking a proton pump inhibitor such as lansoprazol, especially for a period of more than one year, may slightly increase the risk of fractures of the hip, wrist, or vertebrae. Inform your doctor if you have osteoporosis or if you are taking corticosteroids (which may increase the risk of osteoporosis).
If you have been taking Lansoprazol Davur for a long time (more than 1 year), your doctor will probably make regular checks. At your doctor's visits, inform them of any new or abnormal symptoms and circumstances.
Consult your doctor before starting to take lansoprazol:
Taking Lansoprazol Davur 30 mg with other medications
Inform your doctor or pharmacist if you are using or have recently used other medications, including those purchased without a prescription.
Especially, inform your doctor if you are using medications containing any of the following active ingredients, as Lansoprazol Davur may affect their mode of action:
- HIV protease inhibitors such as atazanavir and nelfinavir (used in the treatment of HIV)
- methotrexate (used to treat autoimmune diseases and cancer)
- ketoconazole, itraconazole, rifampicin (used to treat infections)
- digoxin (used to treat heart problems)
- warfarin (used to treat blood clots)
- theophylline (used to treat asthma)
- tacrolimus (used to prevent transplant rejection)
- fluvoxamine (used to treat depression and other psychiatric disorders)
- antacids (used to treat heartburn or acid regurgitation)
- sucralfate (used to heal ulcers)
- St. John's Wort (Hypericum perforatum) (used to treat mild depression)
Taking Lansoprazol Davur 30 mg with food and drinks
To get the best results from your medication, take Lansoprazol Davur at least 30 minutes before meals.
Pregnancy, breastfeeding, and fertility
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor before taking this medication.
Driving and operating machinery
Patients taking Lansoprazol Davur may occasionally experience side effects such as dizziness, vertigo, fatigue, and visual disturbances. If you experience any of these side effects, you should exercise caution as your reaction time may be reduced.
You are the only one responsible for deciding whether you are in a condition to drive vehicles or perform activities that require a high level of concentration. Due to its effects or adverse reactions, one of the factors that may reduce your ability to carry out these operations safely is the use of medications.
In the following sections, you will find the descriptions of these side effects.
Read this prospectus carefully.
If you have any doubts, ask your doctor, nurse, or pharmacist.
Lansoprazol Davur 30 mg contains saccharose and sodium
This medication contains saccharose. If your doctor has indicated that you have an intolerance to certain sugars, consult with them before taking this medication.
This medication contains less than 1 mmol of sodium (23 mg) per capsule; it is essentially "sodium-free".
Follow exactly the administration instructions of this medication indicated by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.
Take the capsule whole with a glass of water. If you have difficulty swallowing the capsule, your doctor will inform you of alternative ways to take the medication. Do not crush or chew the capsules or the contents of an empty capsule, as this will make them not work properly.
If you take Lansoprazol Davur once a day, try to take it at the same time every day. You may get better results if you take Lansoprazol Davur in the morning.
If you take Lansoprazol Davur twice a day, you should take the first dose in the morning and the second at night.
The dose of Lansoprazol Davur depends on your general condition. The normal doses of Lansoprazol Davur for adults are indicated below. In some cases, your doctor may prescribe a different dose and a different duration of treatment.
Treatment of heartburn and acid regurgitation:one capsule of 15 mg or 30 mg per day for 4 weeks. If symptoms persist, inform your doctor. If symptoms do not improve after 4 weeks, consult your doctor.
Treatment of duodenal ulcer:one capsule of 30 mg per day for 2 weeks.
Treatment of gastric ulcer:one capsule of 30 mg per day for 4 weeks.
Treatment of esophagitis due to reflux:one capsule of 30 mg per day for 4 weeks.
Long-term prevention of esophagitis due to reflux:one capsule of 15 mg per day; your doctor may adjust the dose to one capsule of 30 mg per day.
Treatment of Helicobacter pylori infection:The normal dose is one capsule of 30 mg together with two different antibiotics in the morning and one capsule of 30 mg together with two different antibiotics at night. The treatment, usually, will be daily for 7 days.
The recommended antibiotic combinations are as follows:
- 30 mg of Lansoprazol Davur with 250–500 mg of clarithromycin and 1,000 mg of amoxicillin
- 30 mg of Lansoprazol Davur with 250 mg of clarithromycin and 400–500 mg of metronidazole
If you receive anti-infective treatment due to an ulcer, it is unlikely that the ulcer will recur if the infection is treated satisfactorily. To get the best results from your medication, take it at the right time anddo not forget any dose.
Treatment of duodenal or gastric ulcer in patients requiring continuous treatment with NSAIDs:one capsule of 30 mg per day for 4 weeks.
Prevention of duodenal or gastric ulcer in patients requiring continuous treatment with NSAIDs:one capsule of 15 mg per day; your doctor may adjust the dose to one capsule of 30 mg per day.
Zollinger-Ellison syndrome:The initial normal dose is two capsules of 30 mg per day; subsequently, your doctor will decide the best dose for you based on your response to treatment with Lansoprazol Davur.
Use in children
Lansoprazol Davur should not be administered to children.
If you take more Lansoprazol Davur 30 mg than you should
If you take more Lansoprazol Davur than indicated, consult your doctor immediately or contact the Toxicological Information Service, Telephone 915 620 420.
If you forget to take Lansoprazol Davur 30 mg
If you forget to take a dose, take it as soon as possible unless the time for the next dose is near. In this case, skip the missed dose and take the capsules as usual. Do not take a double dose to compensate for the missed dose.
If you interrupt treatment with Lansoprazol Davur 30 mg
Do not stop treatment before time because symptoms have improved. It is possible that your condition has not been fully cured and may recur if you do not complete the entire treatment.
If you have any other doubts about the use of this medication, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everyone will experience them.
The following side effects are frequent (can affect up to 1 in 10 people):
The following side effects are infrequent (can affect up to 1 in 100 people):
The following side effects are rare (can affect up to 1 in 1,000 people):
The following side effects are very rare (can affect up to 1 in 10,000 people):
Unknown frequency(cannot be estimated from available data):
If you are taking proton pump inhibitors such as Lansoprazol Davur, especially for a period of more than one year, it may slightly increase the risk of hip, wrist, and spinal column fractures. Inform your doctor if you have osteoporosis or if you are taking corticosteroids (they may increase the risk of osteoporosis).
Reporting of side effects
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this leaflet. You can also report them directly through the Spanish System for the Pharmacovigilance of Medicines for Human Use:https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Store below 30°C.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date that appears on the packaging, after the expiration date abbreviation. The expiration date is the last day of the month indicated.
Medications should not be disposed of through drains or in the trash. Dispose of packaging and medications you no longer need at the SIGRE collection point of the pharmacy. If in doubt, ask your pharmacist how to dispose of packaging and medications you no longer need. In this way, you will help protect the environment.
Composition of Lansoprazol Davur 30 mg capsules
The capsule components are: Gelatin, titanium dioxide (E171).
The printing ink of the capsules contains shellac, anhydrous ethanol, isopropyl alcohol, propylene glycol, n-butyl alcohol, ammonium hydroxide, potassium hydroxide, iron oxide black (E172).
Appearance of the product and content of the container
Lansoprazol Davur 30 mg capsules arehard-gastroresistent capsules with a white opaque cap and body, filled with beige micropellets. The capsules have been marked with black ink with the letter “L” on the cap and the number “30” on the body.
HDPE bottles with 14 and 28 hard-gastroresistent capsules.
Aluminum/Aluminum blisters with 14 and 28 hard-gastroresistent capsules.
Only some container sizes may be commercially marketed.
Marketing authorization holder and responsible manufacturer
Marketing authorization holder
Teva Pharma, S.L.U.
C/Anabel Segura 11, Edificio Albatros B, 1st floor,
Alcobendas, 28108 Madrid (Spain)
Responsible manufacturer
Teva Pharma S.L.U.
Malpica industrial estate c/C 4.
50016 Zaragoza.
Spain
Last review date of this leaflet: December 2022
The detailed information of this medicine is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS) http://www.aemps.gob.es/
Есть вопросы по этому лекарству или вашим симптомам? Свяжитесь с лицензированным врачом для получения помощи и персонализированного ухода.